Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 99

Published Date: 02 Jan 2024

Category: Food & Beverages

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 481.2 million in 2023 and is forecast to a readjusted size of USD 1197.9 million by 2030 with a CAGR of 13.9% during review period.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.

The Global Info Research report includes an overview of the development of the Human Milk Oligosaccharides (HMO) industry chain, the market status of Infant Formula (2'-FL & 3-FL, LNT & LNnT, etc.), Others (2'-FL & 3-FL, LNT & LNnT, etc.), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Milk Oligosaccharides (HMO).

Regionally, the report analyzes the Human Milk Oligosaccharides (HMO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Milk Oligosaccharides (HMO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Human Milk Oligosaccharides (HMO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Milk Oligosaccharides (HMO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 2'-FL & 3-FL, LNT & LNnT, etc.).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Milk Oligosaccharides (HMO) market.

Regional Analysis: The report involves examining the Human Milk Oligosaccharides (HMO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Milk Oligosaccharides (HMO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Human Milk Oligosaccharides (HMO):
Company Analysis: Report covers individual Human Milk Oligosaccharides (HMO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Milk Oligosaccharides (HMO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infant Formula, Others).

Technology Analysis: Report covers specific technologies relevant to Human Milk Oligosaccharides (HMO). It assesses the current state, advancements, and potential future developments in Human Milk Oligosaccharides (HMO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Milk Oligosaccharides (HMO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.

Market segment by Application
Infant Formula
Others

Major players covered
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Human Milk Oligosaccharides (HMO) from 2019 to 2024.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 2'-FL & 3-FL
1.3.3 LNT & LNnT, etc.
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infant Formula
1.4.3 Others
1.5 Global Human Milk Oligosaccharides (HMO) Market Size & Forecast
1.5.1 Global Human Milk Oligosaccharides (HMO) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030)
1.5.3 Global Human Milk Oligosaccharides (HMO) Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Human Milk Oligosaccharides (HMO) Product and Services
2.1.4 Abbott Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 Inbiose
2.2.1 Inbiose Details
2.2.2 Inbiose Major Business
2.2.3 Inbiose Human Milk Oligosaccharides (HMO) Product and Services
2.2.4 Inbiose Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Inbiose Recent Developments/Updates
2.3 Glycom
2.3.1 Glycom Details
2.3.2 Glycom Major Business
2.3.3 Glycom Human Milk Oligosaccharides (HMO) Product and Services
2.3.4 Glycom Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Glycom Recent Developments/Updates
2.4 Chr. Hansen (Jennewein)
2.4.1 Chr. Hansen (Jennewein) Details
2.4.2 Chr. Hansen (Jennewein) Major Business
2.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Services
2.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Chr. Hansen (Jennewein) Recent Developments/Updates
2.5 Elicityl SA
2.5.1 Elicityl SA Details
2.5.2 Elicityl SA Major Business
2.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Product and Services
2.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Elicityl SA Recent Developments/Updates
2.6 ZuChem
2.6.1 ZuChem Details
2.6.2 ZuChem Major Business
2.6.3 ZuChem Human Milk Oligosaccharides (HMO) Product and Services
2.6.4 ZuChem Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ZuChem Recent Developments/Updates

3 Competitive Environment: Human Milk Oligosaccharides (HMO) by Manufacturer
3.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
3.4.2 Top 6 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
3.5 Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
3.5.1 Human Milk Oligosaccharides (HMO) Market: Region Footprint
3.5.2 Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
3.5.3 Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region
4.1.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
4.1.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
4.1.3 Global Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2030)
4.2 North America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.3 Europe Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.5 South America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.6 Middle East and Africa Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
5.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030)

7 North America
7.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
7.2 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
7.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
7.3.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
7.3.2 North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
8.2 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
8.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
8.3.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
9.3.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
10.2 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
10.3 South America Human Milk Oligosaccharides (HMO) Market Size by Country
10.3.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
10.3.2 South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country
11.3.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Human Milk Oligosaccharides (HMO) Market Drivers
12.2 Human Milk Oligosaccharides (HMO) Market Restraints
12.3 Human Milk Oligosaccharides (HMO) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Human Milk Oligosaccharides (HMO) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Milk Oligosaccharides (HMO)
13.3 Human Milk Oligosaccharides (HMO) Production Process
13.4 Human Milk Oligosaccharides (HMO) Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Milk Oligosaccharides (HMO) Typical Distributors
14.3 Human Milk Oligosaccharides (HMO) Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Human Milk Oligosaccharides (HMO) Product and Services
Table 6. Abbott Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. Inbiose Basic Information, Manufacturing Base and Competitors
Table 9. Inbiose Major Business
Table 10. Inbiose Human Milk Oligosaccharides (HMO) Product and Services
Table 11. Inbiose Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Inbiose Recent Developments/Updates
Table 13. Glycom Basic Information, Manufacturing Base and Competitors
Table 14. Glycom Major Business
Table 15. Glycom Human Milk Oligosaccharides (HMO) Product and Services
Table 16. Glycom Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Glycom Recent Developments/Updates
Table 18. Chr. Hansen (Jennewein) Basic Information, Manufacturing Base and Competitors
Table 19. Chr. Hansen (Jennewein) Major Business
Table 20. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Services
Table 21. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Chr. Hansen (Jennewein) Recent Developments/Updates
Table 23. Elicityl SA Basic Information, Manufacturing Base and Competitors
Table 24. Elicityl SA Major Business
Table 25. Elicityl SA Human Milk Oligosaccharides (HMO) Product and Services
Table 26. Elicityl SA Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Elicityl SA Recent Developments/Updates
Table 28. ZuChem Basic Information, Manufacturing Base and Competitors
Table 29. ZuChem Major Business
Table 30. ZuChem Human Milk Oligosaccharides (HMO) Product and Services
Table 31. ZuChem Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ZuChem Recent Developments/Updates
Table 33. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 34. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 36. Market Position of Manufacturers in Human Milk Oligosaccharides (HMO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
Table 38. Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
Table 39. Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
Table 40. Human Milk Oligosaccharides (HMO) New Market Entrants and Barriers to Market Entry
Table 41. Human Milk Oligosaccharides (HMO) Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 44. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2024) & (USD/Kg)
Table 47. Global Human Milk Oligosaccharides (HMO) Average Price by Region (2025-2030) & (USD/Kg)
Table 48. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 49. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 50. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2024) & (USD/Kg)
Table 53. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2025-2030) & (USD/Kg)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 56. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2024) & (USD/Kg)
Table 59. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2025-2030) & (USD/Kg)
Table 60. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 61. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 62. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 63. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 64. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 65. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 66. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 69. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 70. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 71. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 72. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 73. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 74. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 77. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 78. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 79. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 80. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 81. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 82. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 85. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 86. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 87. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 88. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 89. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 90. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 93. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 94. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 95. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 96. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 97. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 98. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Human Milk Oligosaccharides (HMO) Raw Material
Table 101. Key Manufacturers of Human Milk Oligosaccharides (HMO) Raw Materials
Table 102. Human Milk Oligosaccharides (HMO) Typical Distributors
Table 103. Human Milk Oligosaccharides (HMO) Typical Customers
List of Figures
Figure 1. Human Milk Oligosaccharides (HMO) Picture
Figure 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type in 2023
Figure 4. 2'-FL & 3-FL Examples
Figure 5. LNT & LNnT, etc. Examples
Figure 6. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application in 2023
Figure 8. Infant Formula Examples
Figure 9. Others Examples
Figure 10. Global Human Milk Oligosaccharides (HMO) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Human Milk Oligosaccharides (HMO) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030) & (Tons)
Figure 13. Global Human Milk Oligosaccharides (HMO) Average Price (2019-2030) & (USD/Kg)
Figure 14. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Human Milk Oligosaccharides (HMO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030) & (USD/Kg)
Figure 29. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030) & (USD/Kg)
Figure 32. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Human Milk Oligosaccharides (HMO) Market Drivers
Figure 73. Human Milk Oligosaccharides (HMO) Market Restraints
Figure 74. Human Milk Oligosaccharides (HMO) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Milk Oligosaccharides (HMO) in 2023
Figure 77. Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
Figure 78. Human Milk Oligosaccharides (HMO) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
btl

Related Reports

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Food & Beverages

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 99

Published Date: 02 Jan 2024

Category: Food & Beverages

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 481.2 million in 2023 and is forecast to a readjusted size of USD 1197.9 million by 2030 with a CAGR of 13.9% during review period.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.

The Global Info Research report includes an overview of the development of the Human Milk Oligosaccharides (HMO) industry chain, the market status of Infant Formula (2'-FL & 3-FL, LNT & LNnT, etc.), Others (2'-FL & 3-FL, LNT & LNnT, etc.), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Milk Oligosaccharides (HMO).

Regionally, the report analyzes the Human Milk Oligosaccharides (HMO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Milk Oligosaccharides (HMO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Human Milk Oligosaccharides (HMO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Milk Oligosaccharides (HMO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 2'-FL & 3-FL, LNT & LNnT, etc.).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Milk Oligosaccharides (HMO) market.

Regional Analysis: The report involves examining the Human Milk Oligosaccharides (HMO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Milk Oligosaccharides (HMO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Human Milk Oligosaccharides (HMO):
Company Analysis: Report covers individual Human Milk Oligosaccharides (HMO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Milk Oligosaccharides (HMO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infant Formula, Others).

Technology Analysis: Report covers specific technologies relevant to Human Milk Oligosaccharides (HMO). It assesses the current state, advancements, and potential future developments in Human Milk Oligosaccharides (HMO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Milk Oligosaccharides (HMO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.

Market segment by Application
Infant Formula
Others

Major players covered
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Human Milk Oligosaccharides (HMO) from 2019 to 2024.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 2'-FL & 3-FL
1.3.3 LNT & LNnT, etc.
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infant Formula
1.4.3 Others
1.5 Global Human Milk Oligosaccharides (HMO) Market Size & Forecast
1.5.1 Global Human Milk Oligosaccharides (HMO) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030)
1.5.3 Global Human Milk Oligosaccharides (HMO) Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Human Milk Oligosaccharides (HMO) Product and Services
2.1.4 Abbott Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 Inbiose
2.2.1 Inbiose Details
2.2.2 Inbiose Major Business
2.2.3 Inbiose Human Milk Oligosaccharides (HMO) Product and Services
2.2.4 Inbiose Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Inbiose Recent Developments/Updates
2.3 Glycom
2.3.1 Glycom Details
2.3.2 Glycom Major Business
2.3.3 Glycom Human Milk Oligosaccharides (HMO) Product and Services
2.3.4 Glycom Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Glycom Recent Developments/Updates
2.4 Chr. Hansen (Jennewein)
2.4.1 Chr. Hansen (Jennewein) Details
2.4.2 Chr. Hansen (Jennewein) Major Business
2.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Services
2.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Chr. Hansen (Jennewein) Recent Developments/Updates
2.5 Elicityl SA
2.5.1 Elicityl SA Details
2.5.2 Elicityl SA Major Business
2.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Product and Services
2.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Elicityl SA Recent Developments/Updates
2.6 ZuChem
2.6.1 ZuChem Details
2.6.2 ZuChem Major Business
2.6.3 ZuChem Human Milk Oligosaccharides (HMO) Product and Services
2.6.4 ZuChem Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ZuChem Recent Developments/Updates

3 Competitive Environment: Human Milk Oligosaccharides (HMO) by Manufacturer
3.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
3.4.2 Top 6 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
3.5 Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
3.5.1 Human Milk Oligosaccharides (HMO) Market: Region Footprint
3.5.2 Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
3.5.3 Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region
4.1.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
4.1.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
4.1.3 Global Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2030)
4.2 North America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.3 Europe Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.5 South America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
4.6 Middle East and Africa Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
5.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
6.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
6.3 Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030)

7 North America
7.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
7.2 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
7.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
7.3.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
7.3.2 North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
8.2 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
8.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
8.3.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
9.3.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
10.2 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
10.3 South America Human Milk Oligosaccharides (HMO) Market Size by Country
10.3.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
10.3.2 South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country
11.3.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Human Milk Oligosaccharides (HMO) Market Drivers
12.2 Human Milk Oligosaccharides (HMO) Market Restraints
12.3 Human Milk Oligosaccharides (HMO) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Human Milk Oligosaccharides (HMO) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Milk Oligosaccharides (HMO)
13.3 Human Milk Oligosaccharides (HMO) Production Process
13.4 Human Milk Oligosaccharides (HMO) Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Milk Oligosaccharides (HMO) Typical Distributors
14.3 Human Milk Oligosaccharides (HMO) Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Human Milk Oligosaccharides (HMO) Product and Services
Table 6. Abbott Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. Inbiose Basic Information, Manufacturing Base and Competitors
Table 9. Inbiose Major Business
Table 10. Inbiose Human Milk Oligosaccharides (HMO) Product and Services
Table 11. Inbiose Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Inbiose Recent Developments/Updates
Table 13. Glycom Basic Information, Manufacturing Base and Competitors
Table 14. Glycom Major Business
Table 15. Glycom Human Milk Oligosaccharides (HMO) Product and Services
Table 16. Glycom Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Glycom Recent Developments/Updates
Table 18. Chr. Hansen (Jennewein) Basic Information, Manufacturing Base and Competitors
Table 19. Chr. Hansen (Jennewein) Major Business
Table 20. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Services
Table 21. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Chr. Hansen (Jennewein) Recent Developments/Updates
Table 23. Elicityl SA Basic Information, Manufacturing Base and Competitors
Table 24. Elicityl SA Major Business
Table 25. Elicityl SA Human Milk Oligosaccharides (HMO) Product and Services
Table 26. Elicityl SA Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Elicityl SA Recent Developments/Updates
Table 28. ZuChem Basic Information, Manufacturing Base and Competitors
Table 29. ZuChem Major Business
Table 30. ZuChem Human Milk Oligosaccharides (HMO) Product and Services
Table 31. ZuChem Human Milk Oligosaccharides (HMO) Sales Quantity (Tons), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ZuChem Recent Developments/Updates
Table 33. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 34. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 36. Market Position of Manufacturers in Human Milk Oligosaccharides (HMO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
Table 38. Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
Table 39. Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
Table 40. Human Milk Oligosaccharides (HMO) New Market Entrants and Barriers to Market Entry
Table 41. Human Milk Oligosaccharides (HMO) Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 44. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2024) & (USD/Kg)
Table 47. Global Human Milk Oligosaccharides (HMO) Average Price by Region (2025-2030) & (USD/Kg)
Table 48. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 49. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 50. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2024) & (USD/Kg)
Table 53. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2025-2030) & (USD/Kg)
Table 54. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 55. Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 56. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2024) & (USD/Kg)
Table 59. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2025-2030) & (USD/Kg)
Table 60. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 61. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 62. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 63. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 64. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 65. North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 66. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 69. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 70. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 71. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 72. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 73. Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 74. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 77. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 78. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 79. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 80. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 81. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 82. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 85. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 86. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 87. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 88. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2024) & (Tons)
Table 89. South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2025-2030) & (Tons)
Table 90. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2024) & (Tons)
Table 93. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2025-2030) & (Tons)
Table 94. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2024) & (Tons)
Table 95. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2025-2030) & (Tons)
Table 96. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2024) & (Tons)
Table 97. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2025-2030) & (Tons)
Table 98. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Human Milk Oligosaccharides (HMO) Raw Material
Table 101. Key Manufacturers of Human Milk Oligosaccharides (HMO) Raw Materials
Table 102. Human Milk Oligosaccharides (HMO) Typical Distributors
Table 103. Human Milk Oligosaccharides (HMO) Typical Customers
List of Figures
Figure 1. Human Milk Oligosaccharides (HMO) Picture
Figure 2. Global Human Milk Oligosaccharides (HMO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type in 2023
Figure 4. 2'-FL & 3-FL Examples
Figure 5. LNT & LNnT, etc. Examples
Figure 6. Global Human Milk Oligosaccharides (HMO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application in 2023
Figure 8. Infant Formula Examples
Figure 9. Others Examples
Figure 10. Global Human Milk Oligosaccharides (HMO) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Human Milk Oligosaccharides (HMO) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030) & (Tons)
Figure 13. Global Human Milk Oligosaccharides (HMO) Average Price (2019-2030) & (USD/Kg)
Figure 14. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Human Milk Oligosaccharides (HMO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Human Milk Oligosaccharides (HMO) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030) & (USD/Kg)
Figure 29. Global Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030) & (USD/Kg)
Figure 32. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Human Milk Oligosaccharides (HMO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Human Milk Oligosaccharides (HMO) Market Drivers
Figure 73. Human Milk Oligosaccharides (HMO) Market Restraints
Figure 74. Human Milk Oligosaccharides (HMO) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Milk Oligosaccharides (HMO) in 2023
Figure 77. Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
Figure 78. Human Milk Oligosaccharides (HMO) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
btl

Related Reports

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Food & Beverages

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

jiaGou

Add To Cart

gouMai

Buy Now